 EyePoint Pharmaceuticals EYPT stock is heading higher on Monday thanks to interim results from a Phase 1 clinical trial. The post EYPT Stock: The Clinical Trial News That Has EyePoint Pharma Investors Seeing Green Today appeared first on InvestorPlace. 